De novo generation of short antimicrobial peptides with simple amino acid composition

Regulatory Peptides

Volumn 166, Issue 1-3, 2011, Pages 36-41

  Lee, Sung Hee ^a   Kim, Seo Jin ^a   Lee, Yoo Sup ^a   Song, Min Dong ^a   Kim, Ick Hee ^b   Won, Hyung Sik ^a  

^a Konkuk University   (South Korea)

^b Konkuk University School of Medicine   (South Korea)

Author keywords

Amphipathic helical peptide; De novo design; LKW model peptide; Tryptophan

Indexed keywords

ANTIINFECTIVE AGENT; LEUCINE; LYSINE; OMIGANAN; POLYPEPTIDE ANTIBIOTIC AGENT; TRYPTOPHAN;

AMINO ACID COMPOSITION; AMINO ACID SEQUENCE; ANTIBACTERIAL ACTIVITY; ARTICLE; CIRCULAR DICHROISM; CONTROLLED STUDY; DRUG DESIGN; DRUG POTENCY; DRUG SYNTHESIS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEMOLYSIS; HUMAN; HUMAN CELL; HYDROPHILICITY; HYDROPHOBICITY; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

AMINO ACID SEQUENCE; ANTI-INFECTIVE AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; CIRCULAR DICHROISM; DRUG DESIGN; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HEMOLYSIS; HUMANS; MICROBIAL SENSITIVITY TESTS; PEPTIDES;

NEGIBACTERIA; POSIBACTERIA;

EID: 78650179473     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2010.08.010     Document Type: Article

References (52)

1. Diamond G., Beckloff N., Weinberg A., Kisich K.O. The roles of antimicrobial peptides in innate host defense. Curr Pharm Des 2009, 15:2377-2392.
2. Zaiou M. Multifunctional antimicrobial peptides: therapeutic targets in several human diseases. J Mol Med 2007, 85:317-329.
3. Ginsburg I., Koren E. Are cationic antimicrobial peptides also 'double-edged swords?. Expert Rev Anti Infect Ther 2008, 6:453-462.
4. Jenssen H., Hamill P., Hancock R.E.W. Peptide antimicrobial agents. Clin Microbiol Rev 2006, 19:491-511.
5. Ulvatne H. Antimicrobial peptides: potential use in skin infections. Am J Clin Dermatol 2003, 4:591-595.
6. Mader J.S., Hoskin D.W. Cationic antimicrobial peptides as novel cytotoxic agents for cancer treatment. Expert Opin Investig Drugs 2006, 15:933-946.
7. Papo N., Shai Y. Host defense peptides as new weapons in cancer treatment. Cell Mol Life Sci 2005, 62:784-790.
8. Rivas L., Luque-Ortega J.R., Andreu D. Amphibian antimicrobial peptides and Protozoa: lessons from parasites. Biochim Biophys Acta 2009, 1788:1570-1581.
9. Abdel-Wahab Y.H., Marenah L., Flatt P.R., Conlon J.M. Insulin releasing properties of the temporin family of antimicrobial peptides. Protein Pept Lett 2007, 14:702-707.
10. Abdel-Wahab Y.H., Power G.J., Ng M.T., Flatt P.R., Conlon J.M. Insulin-releasing properties of the frog skin peptide pseudin-2 and its [Lys18]-substituted analogue. Biol Chem 2008, 389:143-148.
11. Gubern C., López-Bermejo A., Biarnés J., Vendrell J., Ricart W., Fernández-Real J.M. Natural antibiotics and insulin sensitivity: the role of bactericidal/permeability-increasing protein. Diabetes 2006, 55:216-224.
12. Kim J.H., Lee J.O., Jung J.H., Lee S.K., You G.Y., Park S.J., et al. Gaegurin-6 stimulates insulin secretion through calcium influx in pancreatic β Rin5mf cells. Regul Pept 2009, 159:123-128.
13. Marenah L., Flatt P.R., Orr D.F., Shaw C., Abdel-Wahab Y.H.A. Skin secretions of Rana saharica frogs reveal antimicrobial peptides esculentins-1 and -1B and brevinins-1E and -2EC with novel insulin releasing activity. J Endocrinol 2006, 188:1-9.
14. Giuliani A., Pirri G., Nicoletto S.F. Antimicrobial peptides: an overview of a promising class of therapeutics. Cent Eur J Biol 2007, 2:1-33.
15. Gordon Y.J., Romanowski E.G., McDermott A.M. A review of antimicrobial peptides and their therapeutic potential as anti-infective drugs. Curr Eye Res 2005, 30:505-515.
16. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002, 415:389-395.
17. Rubinchik E., Dugourd D., Algara T., Pasetka C., Friedland H.D. Antimicrobial and antifungal activities of novel cationic antimicrobial peptide, omigana, in experimental skin colonization models. Int J Antimicrob Agents 2009, 34:457-461.
18. Oyston P.C.F., Fox M.A., Richards S.J., Clark G.C. Novel peptides therapeutics for treatment of infections. J Med Microbiol 2009, 58:977-987.
19. Won H.S., Jung S.J., Kim H.E., Seo M.D., Lee B.J. Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5. J Biol Chem 2004, 279:14784-14791.
20. Tossi A., Sandri L., Giangaspero A. Amphipathic, α-helical antimicrobial peptides. Biopolymers 2000, 55:4-30.
21. Zelezetsky I., Tossi A. Alpha-helical antimicrobial peptides - using a sequence template to guide structure-activity relationships studies. Biochim Biophys Acta 2006, 1758:1436-1449.
22. Oren Z., Shai Y. Mode of action of linear amphipathic α-helical antimicrobial peptides. Biopolymers 1998, 47:451-463.
23. Shai Y. Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by α-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim Biophys Acta 1999, 1462:55-70.
24. Yeman M.R., Yount N.Y. Mechanisms of antimicrobial peptide action and resistance. Pharmacol Rev 2003, 55:27-55.
25. Nielsen S.L., Frimodt-Møller N., Kragelund B.B., Hansen P.R. Structure-activity study of the antibacterial peptide fallaxin. Protein Sci 2007, 16:1969-1976.
26. Dathe M., Meyer J., Beyermann M., Maul B., Hoischen C., Bienert M. General aspects of peptide selectivity towards lipid bilayers and cell membranes studied by variation of the structural parameters of amphipathic helical model peptides. Biochim Biophys Acta 2002, 1558:171-186.
27. Fernández-Vidal M., Jayasinghe S., Ladokhin A.S., White S.H. Folding amphipathic helices into membranes: amphiphilicity trumps hydrophobicity. J Mol Biol 2007, 370:459-470.
28. Chou H.T., Kuo T.Y., Chiang J.C., Pei M.J., Yang W.T., Yu H.C., et al. Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp. Int J Antimicrob Agents 2008, 32:130-138.
29. Chen Y., Mant C.T., Farmer S.W., Hancock R.E.W., Vasil M.L., Hodges R.S. Rational design of α-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index. J Biol Chem 2005, 280:12316-12329.
30. Avrahami D., Oren Z., Shai Y. Effect of multiple aliphatic amino acids substitutions on the structure, function, and mode of action of diastereomeric membrane active peptides. Biochemistry 2001, 40:12591-12603.
31. Bessalle R., Gorea A., Shalit I., Metzger J.W., Dass C., Desiderio D.M., et al. Structure-function studies of amphiphilic antibacterial peptides. J Med Chem 1993, 36:1203-1209.
32. Béven L., Castano S., Dufourcq J., Wieslander Å., Wróblewski H. The antibiotic activity of cationic linear amphipathic peptides: lessons from the action of leucine/lysine copolymers on bacteria of the class Mollicutes. Eur J Biochem 2003, 270:2207-2217.
33. Blondelle S.E., Houghten R.A. Design of model amphipathic peptides having potent antimicrobial activities. Biochemistry 1992, 31:12688-12694.
34. Dathe M., Wieprecht T., Nikolenko H., Handel L., Maloy W.L., MacDonald D.L., et al. Hydrophobicity, hydrophobic moment and angle subtended by charged residues modulate antibacterial and haemolytic activity of amphipathic helical peptides. FEBS Lett 1997, 403:208-212.
35. Deslouches B., Phadke S.M., Lazarevic V., Cascio M., Islam K., Montelaro R.C., et al. De novo generation of cationic antimicrobial peptides: influence of length and tryptophan substitution on antimicrobial activity. Antimicrob Agents Chemother 2005, 49:316-322.
36. Jin Y., Mozsolits H., Hammer J., Zmuda E., Zhu F., Zhang Y., et al. Influence of tryptophan on lipid binding of lenear amphipathic cationic antimicrobial peptides. Biochemistry 2003, 42:9395-9405.
37. Jin Y., Hammer J., Pate M., Zhang Y., Zhu F., Zmuda E., et al. Antimicrobial activities and structures of two linear cationic peptide families with various amphipathic -sheet and -helical potentials. Antimicrob Agents Chemother 2005, 49:4957-4964.
38. Oren Z., Ramesh J., Avrahami D., Suryaprakash N., Shai Y., Jelinek R. Structures and mode of membrane interaction of a short α helical lytic peptide and its diastereomer determined by NMR, FTIR, and fluorescence spectroscopy. Eur J Biochem 2002, 269:3869-3880.
39. Shin S.Y., Hahm K.S. A short α-helical antimicrobial peptide with antibacterial selectivity. Biotechnol Lett 2004, 26:735-739.
40. Chou P.Y., Fasman G.D. Conformational parameters for amino acids in helical, α-sheet, and random coil regions calculated from proteins. Biochemistry 1974, 13:211-222.
41. Won H.S., Park S.H., Kim H.E., Hyun B., Kim M., Lee B., et al. Effects of a tryptophanyl substitution on the structure and antimicrobial activity of C-terminally truncated gaegurin 4. Eur J Biochem 2002, 269:4367-4374.
42. Won H.S., Seo M.D., Jung S.J., Lee S.J., Kang S.J., Son W.S., et al. Structural determinants for the membrane interaction of novel bioactive undecapeptides derived from gaegurin 5. J Med Chem 2006, 49:4886-4895.
43. Hu W., Lee K.C., Cross T.A. Tryptophans in membrane proteins: indole ring orientations and functional implications in the gramicidin channel. Biochemistry 1993, 32:7035-7047.
44. Oh D., Shin S.Y., Lee S., Kang J.H., Kim S.D., Ryu P.D., et al. Role of the hinge region and the tryptophan residue in the synthetic antimicrobial peptides, cecropin A(1-8)-Magainin 2(1-12) and its analogues, on their antibiotic activities and structures. Biochemistry 2000, 39:11855-11964.
45. Park K., Oh D., Shin S.Y., Hahm K.S., Kim Y. Structural studies of porcine myeloid antibacterial peptide PMAP-23 and its analogues in DPC micelles by NMR spectroscopy. Biochem Biophys Res Commun 2002, 290:204-212.
46. Ridder A.N., Morein S., Stam J.G., Kuhn A., de Kruijff B., Killian J.A. Analysis of the role of interfacial tryptophan residues in controlling the topology of membrane proteins. Biochemistry 2000, 39:6521-6528.
47. Epand R.M., Vogel H.J. Diversity of antimicrobial peptides and their mechanisms of action. Biochim Biophys Acta 1999, 1462:11-28.
48. Sitaram N. Antimicrobial peptides with unusual amino acid compositions and unusual structures. Curr Med Chem 2006, 13:679-696.
49. Won H.S., Kang S.J., Lee B.J. Action mechanism and structural requirements of the antimicrobial peptides, gaegurins. Biochim Biophys Acta 2009, 1788:1620-1629.
50. Ubukata K., Yamashita N., Konno M. Occurrence of a β-lactam-inducible penicillin-binding protein in methicillin-resistant staphylococci. Antimicrob Agents Chemother 1985, 5:851-857.
51. Eisenberg D. Three-dimensional structure of membrane and surface proteins. Annu Rev Biochem 1984, 53:595-623.
52. Zhu W.L., Nan Y.H., Hahm K.S., Shin S.Y. Cell selectivity of an antimicrobial peptide melittin diastereomer with D-amino acid in the leucine zipper sequence. J Biochem Mol Biol 2007, 40:1090-1094.